Do medical patients need to receive pharmacologic prophylaxis for the prevention of venous thromboembolism?

Internal and Emergency Medicine

Volumn 7, Issue SUPPL. 3, 2012, Pages 189-192

  Ageno, Walter ^a,b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Medical patient; New oral anticoagulants; Prophylaxis; Risk assessment models; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; HUMAN; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84867703189     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-012-0800-2     Document Type: Article

References (19)

1. Goldhaber SZ, Tapson VF (2004) A prospective registry of 5, 451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 93: 259-262.
2. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ (2007) Venous thromboembolism in the outpatient setting. Arch Intern Med 167: 1471-1475.
3. Mismetti P, Laporte-Simitsidis S, Tardy B, Cucherat M, Buchmuller A, Juillard-Delsard D, Decousus H (2000) Prevention of venous thromboembolism in internal medicine with unfractionated or low molecular weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 83: 14-19.
4. Samama MM, Cohen AT, Darmon JY et al (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 341: 793-800.
5. Leizorovicz A, Cohen AT, Turpie AGG, Olsson CG, Vaitkus PT, Goldhaber SZ (2004) Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110: 874-879.
6. Cohen AT, Davidson BI, Gallus AS et al (2006) Efficacy and safety of fondaparinux for the prevention of VTE in older acute medical patients. BMJ 332: 325-329.
7. Dentali F, Douketis JD, Gianni M, Lim W, Crowther M (2007) Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Inter Med 146: 278-288.
8. Kahn S, Lim W, Dunn AS et al (2012) Prevention of VTE in non surgical patients. Chest 141(2): Suppl: e195S-e226S.
9. Cohen AT, Tapson VF, Bergmann JF et al (2008) Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 371: 387-394.
10. Tapson VF, Decousus H, Pini M et al (2007) Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 132: 936-945.
11. Gussoni G, Campanini M, Silingardi M, Scannapieco G, Mazzone A, Magni G, Valerio A, Iori I, Ageno W (2009) In hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study. Thromb Haemost 101: 893-901.
12. Ageno W, Squizzato A, Ambrosini F, Dentali F, Marchesi C, Mera V, Steidl L, Venco A (2002) Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 87: 746-750.
13. Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based-clinical practice guidelines (8th edition). Chest 133: 381-453.
14. Barbar S, Noventa F, Rossetto V et al (2010) A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 8: 2450-2457.
15. Lloyd NS, Douketis JD, Moinuddin I, Lim W, Crowther MA (2008) Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis. J Thromb Haemost 6: 405-414.
16. Decousus H, Tapson VF, Bergmann JF et al (2011) Factors at admission associated with bleeding risk in medical patients. Findings from the IMPROVE Investigators. Chest 139: 69-79.
17. Hull RD, Schellong SM, Tapson VF et al (2010) Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med 153: 8-18.
18. Cohen AT, Spiro TE, Büller HR et al (2011) Rivaroxaban compared with enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients. American College of Cardiology Congress 60th Annual Scientific Session, New Orleans, USA.
19. Goldhaber SZ, Leizorovicz A, Kakkar AK et al (2011) Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 365: 2167-2177.